Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | REMS PATIENT |
Description | Welcome to the REMS Programs Administered by Bristol Myers Squibb To avoid embryo-fetal exposure, Risk Evaluation and Mitigation Strategy (REMS) programs |
Keywords | N/A |
WebSite | celgeneremspharmacyportal.com |
Host IP | 45.60.150.161 |
Location | United States |
Site | Rank |
US$6,758,595
Last updated: 2023-05-14 11:45:52
celgeneremspharmacyportal.com has Semrush global rank of 1,566,051. celgeneremspharmacyportal.com has an estimated worth of US$ 6,758,595, based on its estimated Ads revenue. celgeneremspharmacyportal.com receives approximately 779,838 unique visitors each day. Its web server is located in United States, with IP address 45.60.150.161. According to SiteAdvisor, celgeneremspharmacyportal.com is safe to visit. |
Purchase/Sale Value | US$6,758,595 |
Daily Ads Revenue | US$6,239 |
Monthly Ads Revenue | US$187,162 |
Yearly Ads Revenue | US$2,245,933 |
Daily Unique Visitors | 51,990 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
celgeneremspharmacyportal.com. 28800 IN | A | IP: 45.60.150.161 | |
celgeneremspharmacyportal.com. 28800 IN | A | IP: 45.60.170.161 | |
celgeneremspharmacyportal.com. 28800 IN | NS | NS Record: ns3.bms.com. | |
celgeneremspharmacyportal.com. 28800 IN | NS | NS Record: ns4.bms.com. | |
celgeneremspharmacyportal.com. 28800 IN | NS | NS Record: ns1.bms.com. | |
celgeneremspharmacyportal.com. 28800 IN | NS | NS Record: ns2.bms.com. | |
celgeneremspharmacyportal.com. 28800 IN | MX | MX Record: 10 custmx.cscdns.net. | |
celgeneremspharmacyportal.com. 28800 IN | TXT | TXT Record: globalsign-domain-verification=91EE2763250C8EAD6A113B4AA3D1CBFD | |
celgeneremspharmacyportal.com. 28800 IN | TXT | TXT Record: p11wdkkkbjb8dd8q8jhr03dhvdzrfb6w | |
celgeneremspharmacyportal.com. 28800 IN | TXT | TXT Record: v=spf1 a ptr a:email.celgene.com -all |
Welcome to the REMS Programs Administered by Bristol Myers Squibb To avoid embryo-fetal exposure, Risk Evaluation and Mitigation Strategy (REMS) programs are mandatory for the REMS products THALOMID ® (thalidomide), POMALYST ® (pomalidomide), REVLIMID ® (lenalidomide) and generic lenalidomide. The THALOMID REMS ® program, Lenalidomide REMS program and POMALYST REMS ® program require prescribers and pharmacists to be certified and patients to enroll and comply with all of the requirements for each program. If you would like to obtain more information about any of the Bristol Myers Squibb-administered REMS programs, please click on the program name below: Visit www.LenalidomideREMS.com , to learn more about the Lenalidomide REMS program. Visit www.POMALYSTREMS.com , to learn more about the POMALYST REMS ® program. Visit www.THALOMIDREMS.com , to learn more about the THALOMID REMS ® program. To complete a REMS related task, please select the appropriate option from below: Prescribers: |
HTTP/1.1 301 Moved Permanently Location: https://celgeneremspharmacyportal.com/ Content-Length: 0 Connection: close HTTP/2 302 location: /REMSPharmacyPortal/remspharmacy/portal/REMSPharmacyPortal.portal cache-control: no-cache pragma: no-cache set-cookie: visid_incap_2668664=R3j/v8imRXCrWG5pBTWzhA46xGEAAAAAQUIPAAAAAAAQrcT2EX2hxxi8eGyT01aJ; expires=Fri, 23 Dec 2022 06:37:11 GMT; HttpOnly; path=/; Domain=.celgeneremspharmacyportal.com set-cookie: incap_ses_1292_2668664=aChRTvgtqwmntqbHdhvuEQ46xGEAAAAAvIbm/b5ATZXg4o+CCl1wuQ==; path=/; Domain=.celgeneremspharmacyportal.com x-cdn: Imperva x-iinfo: 11-63625287-63625288 NNNN CT(28 57 0) RT(1640249870253 0) q(0 0 1 0) r(1 1) U6 HTTP/2 200 cache-control: no-store date: Thu, 23 Dec 2021 08:56:39 GMT pragma: no-cache content-type: text/html; charset=UTF-8 expires: Thu, 01 Jan 1970 00:00:00 GMT x-frame-options: SAMEORIGIN set-cookie: JSESSIONID=p5jmgbT-IWInQnep451zETnLI1MXL8ZQxL5f-_b9Ld5QKVSDL4dO!1770499310!699152808; path=/; secure; HttpOnly set-cookie: NSC_JOro1ytqe53qvusblqrc1ad4eqxwuc3=ffffffffaf10130645525d5f4f58455e445a4a422d6a;path=/;secure;httponly set-cookie: visid_incap_2668664=R3j/v8imRXCrWG5pBTWzhA46xGEAAAAAQUIPAAAAAAAQrcT2EX2hxxi8eGyT01aJ; expires=Fri, 23 Dec 2022 06:37:11 GMT; HttpOnly; path=/; Domain=.celgeneremspharmacyportal.com set-cookie: incap_ses_1292_2668664=5oYAfHEGlW+ntqbHdhvuEQ46xGEAAAAALrouX+/zFibtuTf0b+11Dw==; path=/; Domain=.celgeneremspharmacyportal.com x-cdn: Imperva x-iinfo: 11-63625309-63625310 NNNN CT(28 28 0) RT(1640249870387 0) q(0 0 1 0) r(1 1) U6 |
Domain Name: CELGENEREMSPHARMACYPORTAL.COM Registry Domain ID: 1787412647_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-03-15T05:16:14Z Creation Date: 2013-03-19T13:08:48Z Registry Expiry Date: 2022-03-19T13:08:48Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.BMS.COM Name Server: NS2.BMS.COM Name Server: NS3.BMS.COM Name Server: NS4.BMS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-26T07:46:51Z <<< |